Department of Chemistry and Applied Biosciences, Swiss Federal Institute of Technology (ETH Zurich), Zurich, Switzerland.
Philochem AG, Otelfingen, Switzerland.
Nat Chem. 2021 Jun;13(6):540-548. doi: 10.1038/s41557-021-00660-y. Epub 2021 Apr 8.
The encoding of chemical compounds with amplifiable DNA tags facilitates the discovery of small-molecule ligands for proteins. To investigate the impact of stereo- and regiochemistry on ligand discovery, we synthesized a DNA-encoded library of 670,752 derivatives based on 2-azido-3-iodophenylpropionic acids. The library was selected against multiple proteins and yielded specific ligands. The selection fingerprints obtained for a set of protein targets of pharmaceutical relevance clearly showed the preferential enrichment of ortho-, meta- or para-regioisomers, which was experimentally verified by affinity measurements in the absence of DNA. The discovered ligands included novel selective enzyme inhibitors and binders to tumour-associated antigens, which enabled conditional chimeric antigen receptor T-cell activation and tumour targeting.
利用可扩增 DNA 标签对化合物进行编码,有助于发现小分子蛋白配体。为了研究立体化学和区域化学对配体发现的影响,我们合成了一个基于 2-叠氮基-3-碘代苯丙酸的 670752 个衍生物的 DNA 编码文库。该文库针对多种蛋白质进行了筛选,得到了特异性配体。针对一组具有药物相关性的蛋白质靶标获得的选择指纹图谱清楚地显示了邻位、间位或对位区域异构体的优先富集,这通过在没有 DNA 的情况下进行的亲和力测量得到了实验验证。所发现的配体包括新型选择性酶抑制剂和肿瘤相关抗原的结合物,这使条件性嵌合抗原受体 T 细胞激活和肿瘤靶向成为可能。